# Castle Biosciences Inc: Form 8-K, filed Nov 9, 2023

- Company: [Castle Biosciences Inc](/companies/cstl.md) (CIK 1447362)
- Form: 8-K
- Filed: 2023-11-09
- Accepted by EDGAR: Nov 9, 2023, 17:25 ET
- Period: 2023-11-03
- Accession: 0001193125-23-274634
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447362/000119312523274634/d530518d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447362/000119312523274634/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447362/000119312523274634/d530518d8k.htm

Filed Nov 9, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-274634. Last ingested by Listed: Nov 14, 2026, 19:05 ET. No prices; not investment advice.
